UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Valley National Advisers Inc.

Valley National Advisers Inc. lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.8% during the 3rd quarter, HoldingsChannel reports. The firm owned 1,064 shares of the healthcare conglomerate’s stock after selling 333 shares during the period. Valley National Advisers Inc.’s holdings in UnitedHealth Group were worth $622,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Delta Financial Group Inc. grew its position in UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after buying an additional 17 shares during the period. Signature Resources Capital Management LLC increased its stake in UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares in the last quarter. Saxony Capital Management LLC boosted its position in UnitedHealth Group by 3.5% during the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after purchasing an additional 18 shares in the last quarter. GoalVest Advisory LLC raised its stake in shares of UnitedHealth Group by 0.6% during the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock worth $1,591,000 after buying an additional 18 shares during the last quarter. Finally, Fiduciary Group LLC grew its stake in UnitedHealth Group by 0.5% in the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after acquiring an additional 18 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 0.7 %

NYSE UNH opened at $564.56 on Monday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63. The firm’s fifty day simple moving average is $583.52 and its 200-day simple moving average is $538.58. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $521.33 billion, a PE ratio of 36.78, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the prior year, the company posted $6.56 earnings per share. UnitedHealth Group’s revenue for the quarter was up 9.2% on a year-over-year basis. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.49%. UnitedHealth Group’s dividend payout ratio is 54.72%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of analyst reports. KeyCorp initiated coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 target price on the stock. Cantor Fitzgerald boosted their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. HSBC lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Stephens reduced their price target on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.